Consumables was Bionano Genomics’s largest product and service line in fiscal 2025, bringing in $27.94M of $57.02M (49%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | — | — | — | — | |||||
| Consumables | $13.46M | $22.31M | $25.55M | $27.94M | |||||
| Consumable Revenue | — | — | — | — | |||||
| Instruments | $17.13M | $20.00M | $16.09M | $12.73M | |||||
| Instrument Revenue | — | — | — | — | |||||
| Software | $10.25M | $11.14M | $12.38M | $12.82M | |||||
| Service & Other Revenue | $14.75M | $18.78M | $7.54M | $3.53M | |||||
| Other Revenue | — | — | — | — | |||||
| Total | $55.60M | $72.23M | $61.55M | $57.02M |
Bionano Genomics brought in $57.02M from its four product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 7.4% from $61.55M in fiscal 2024. Consumables was the largest at $27.94M (49.0%), ahead of Software at $12.82M (22.5%) and Instruments at $12.73M (22.3%). The remaining line, Service & Other Revenue, brought in $3.53M.
Compared with fiscal 2024, Consumables grew fastest, up 9.4% to $27.94M, while Service & Other Revenue fell the most, down 53.2% to $3.53M. From fiscal 2022 to 2025, combined revenue from these lines grew from $55.60M to $57.02M, a compound annual growth rate of 0.8%. Consumables' share of the total rose from 24.2% to 49.0%.
Emea was Bionano Genomics’s largest region in fiscal 2025, bringing in $28.22M of $57.02M (49%).
| Geography | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Americas | $27.72M | $36.04M | $27.30M | $24.36M | |||||
| Emea | $17.92M | $25.93M | $28.47M | $28.22M | |||||
| Emeia | — | — | — | — | |||||
| North America | — | — | — | — | |||||
| Asia Pacific | $9.96M | $10.27M | $5.79M | $4.44M | |||||
| Total | $55.60M | $72.23M | $61.55M | $57.02M |
Bionano Genomics brought in $57.02M from its three regions in fiscal 2025, the year ended December 31, 2025. That was down 7.4% from $61.55M in fiscal 2024. Emea was the largest at $28.22M (49.5%), ahead of Americas at $24.36M (42.7%) and Asia Pacific at $4.44M (7.8%).
Compared with fiscal 2024, every region above 2% of revenue shrank. Emea held up best, down 0.9% to $28.22M, and Asia Pacific fell the most, down 23.3% to $4.44M. From fiscal 2022 to 2025, combined revenue from these regions grew from $55.60M to $57.02M, a compound annual growth rate of 0.8%. Emea's share of the total rose from 32.2% to 49.5%.
Bionano Genomics (BNGO) reports its revenue by product and service and by geography. In fiscal 2025, Consumables was its largest product and service line, bringing in $27.94M (49.0% of the total), followed by Software at $12.82M (22.5%).
Consumables was Bionano Genomics' largest product and service line in fiscal 2025, bringing in $27.94M, or 49.0% of the $57.02M total across its four product and service lines.
Emea was Bionano Genomics' largest region in fiscal 2025, bringing in $28.22M, or 49.5% of the $57.02M total across its three regions.
Among Bionano Genomics' product and service lines that make up at least 2% of revenue, Consumables grew fastest in fiscal 2025, up 9.4% from $25.55M to $27.94M.
Every figure comes from Bionano Genomics' annual financial filings, as reported. Each line keeps the name Bionano Genomics gives it, and years follow its fiscal calendar.
Bionano Genomics' revenue by product and service goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.